FMO5 and neoplasm: The mechanisms by which N1 TAN show anti-tumor activities are antibody-dependent cytotoxicity by neutrophil elastase (NE), activation of innate and adaptive immune cells such as lymphocytes, NK cells and dendritic cells, and tumor cell suppression through ROS production by increasing NADPH oxidase activity [38,39].